uptake of glutamine was not changed. Folate, a nontoxic analog of MTX, did not exhibit these membrane effects, nor did it prevent the effect of MTX, suggesting that the NH2 in position 4 of the pteridine ring of the MTX molecule is involved in the MTX response. A strain bearing the nonsense mutation amiA9, selected for MTX resistance, did not exhibit increased membrane potential after MTX pretreatment. This suggests that MTX interacts with a specific membrane component in S. pneumoniae. A resulting change in ion permeability could lead to changes in the magnitude of the A+. The MTX-sensitive component is altered or absent in mutant amiA9.
Antifolates act principally on the target enzyme dihydrofolate reductase (EC 1.5.1.3) in procaryotes and eucaryotes, resulting in a block in the conversion offolate and dihydrofolates to tetrahydrofolates. As a consequence of this block and of the resulting deficiency in tetrahydrofolate derivatives, depression of thymidylate synthesis with a consequent failure in DNA synthesis and arrest of cell division occurs (for a review, see reference 2). However, other effects of methotrexate (MTX) have been observed in several cell lines (8-10, 16, 17) . Co-workers and I found that incubation of the bacterium Streptococcus pneumoniae with MTX altered the lipid composition of the membrane of this organism, resulting in a higher content of unsaturated fatty acids and cardiolipin (14) . The MTX-resistant mutant amiA9 did not show any alteration in the lipid composition of its membrane after MTX treatment (14) . In addition, this mutant possessed a wild-type-like dihydrofolate reductase (15) , was prototrophic for thymine (unpublished data), and had a reduced electric transmembrane potential (A+) compared with the wild type (13a). MTX inhibition was not overcome by chemicals such as folate, 5-formyltetrahydrofolate, thymine, thiamine, methylcytosine, 2-methyladenine, or a mixture of thymidine, glycine, and 2-methyladenine even when their concentrations in the growth medium were 20 times higher than the MTX concentration (Trombe, Ph.D. thesis, Universite Paul Sabatier, Toulouse, France, 1972 ). Moreover, the high level of resistance of the mutant amiA9 cells could not be explained by an alteration in MTX uptake (manuscript in preparation). It is possible that MTX has a target in addition to the dihydrofolate reductase. Such a target would be defective or absent in the amiA9 mutant. The alteration of the lipid composition of the S. pneumoniae membrane by MTX and the resistance of the amiA9 mutant to this effect impelled me to check whether other membrane functions, such as uptake of amino acids, are altered in the wild type and mutant amiA9 in response to MTX.
My results indicate that MTX-treated bacteria have an increased Aqi compared with untreated controls, with associated increased uptake for substrates of Al-dependent transport systems. This effect on transport is specific for the MTX molecule, since the closely related compound folic acid did not show such an effect. Thus, the effects of MTX on membrane properties in S. pneumoniae seem to be mediated by a specific component, which is altered in the MTXresistant mutant amiA9.
MATJ:RIALS AND METHODS
Strains and growth medium. MTX-sensitive strain S. pneumoniae Cl3 was derived from strain R36A (13) . Strain Cl3 is auxotrophic for valine, leucine, isoleucine, arginine, asparagine, histidine, glutamine, and uracil and does not require folic acid for growth in synthetic medium (11) . Bacterial growth is inhibited by 10-6 M MTX in peptone-yeast extract medium (15) and by 4 x 10-M MTX in defined medium (11) .
Strain amiA9, which carries the amiA9 nonsense mutation (5), was chosen from 50 mutants with mutations at the same locus as a representative MTX-resistant strain. Growth and preparation of cells for transport studies have been described elsewhere (13a).
MTX treatment. Bacteria were collected in late exponential phase by centrifugation and resuspension in the same medium which contained MTX at the required concentration and was kept at 37°C. After the desired preincubation periods, the cells were harvested by centrifugation at 4°C, washed with the salt-buffered medium described below, and suspended for uptake studies. Controls cells were obtained by suspending the bacteria in MTX-free or folate-containing media.
Uptake assay. Unless otherwise stated, the bacteria were diluted to concentrations of 0.03 to 0.3 mg of protein per ml in buffer which consisted of 120 mM NaCl, 52 mM NH4Cl, 7.5 mM KCl, 20 mM NaH2PO4, 40 mM Tris base (Sigma Chemical Co., St. Louis, Mo.), and 0.4% (wt/vol) glucose (pH 7.55) (11) . The cells were allowed to glycolyze at 20°C for 2 min. Uptake was initiated by adding radioactivitely labeled substrates, and 0.1-ml samples were removed at intervals, filtered through glass microfiber filters (Whatman GF/B), and washed three times with 3 ml of buffer without glucose. (12) and 0.3 mg of proteins (9 Isoleucine, glutamine, and MTX uptake in MTX-treated wild-type and mutant S. pneumoniae cells. Treatment of the wild-type strain with MTX caused an increase in isoleucine uptake (Fig. 1) . Both the rate of uptake and the accumulation at steady-state were enhanced as MTX concentrations were increased in the range from 10-7 to 10-5 M (Fig. 1A) . By contrast, in the MTX-resistant mutant an MTX concentration of lo4 M was required before an increase in the rate of uptake and accumulation of isoleucine was seen (Fig. 1B) . Glutamine uptake by wild-type cells, assayed under parallel [3H]MTX (1 x 10-5 M; 500 cpm/pmol) uptake was then assayed.
Symbols: A, wild-type strain; A, mutant strain. and in Streptococcus faecalis (7) . Next, MTX uptake was monitored in MTX-treated bacteria. Uptake of MTX was increased in MTX-treated cells compared with untreated controls, and this effect was not observed in strain amiA9 (Fig. 3) . Since MTX uptake may occur by a mechanism dependent on Atv, it seemed likely that MTX treatment of S. pneumoniae stimulated those transport systems deriving their energy from A1v. MTX-resistant mutant amiA9 was less sensitive to the MTX effect than the wild-type strain Moreover, stimulation of isoleucine and MTX uptake was seen in MTX-treated bacteria, but not in folate-treated cells (Table 2) . Since MTX and folate differ by an NH2 in the pteridine ring, the amino group may be essential for the stimulatory effect.
I next checked the effect of MTX treatment on A4p in S. pneumoniae directly. In wild-type cells pretreated with 10-5 M MTX, the Atl was 160 ± 5 mV, compared with 130 ± 5 mV for untreated cells. At the pH value used in these experiments (pH 7.55), the ApH was too small (-0.15 U), NDb and accurate measurements of eventual ApH changes were not possible. The influence of A on the 30-s uptake of isoleucine was examined next. Wild-type bacteria were preincubated with different amounts of the permeant cation triphenylmethylphosphonium in order to partially depolarize the membranes. Both the initial rate of isoleucine uptake and A* were decreased by triphenylmethylphosphonium accumulation (Fig. 4) .
Hyperpolarization of the membrane occurred in the wildtype strain at MTX concentrations between 10-7 and 10-5 whereas depolarization may have occurred in the presence of 10-4 M MTX, as measured by the changes in the initial rate of isoleucine uptake when the data of Fig. 1 were replotted in Fig. 5 . This response to MTX apparently can be changed by mutation, since 10-4 M MTX was necessary to produce the effect in mutant amiA9 (Fig. 5) .
Other observations on the MTX effect. When bacteria were treated with 5 x 10-7, 1 X 10-6, or 5 x 10-6 M MTX for different times, no significant effect on the rate of isoleucine uptake was observed before 30 min (data not shown). I tested whether induction of proteins caused this lag. Addition of 100 ,ug of chloramphenicol per ml resulted in a 90% stimulation of [3H]MTX uptake by MTX pretreatment, whereas in the absence of chloramphenicol the stimulation was 70% of the control value. The toxic effects of MTX on wild-type cells may result from a combination of changes in uptake, accumulation of metabolites, alteration of intracellular pools, and enhancement of MTX uptake, as well as other factors not studied.
Another consequence of a change in A* could be in the activity of membrane-localized enzymes, which could result in altered phosphatidylglycerol and cardiolipin content of membranes (14) . It has been shown in other bacteria that the biosynthetic mechanisms for these polar lipids are located within the membrane (3) .
Therefore, I propose that S. pneumoniae cells have an MTX target in their plasma membranes and that the 4-amino residue of the pteridine ring of MTX is essential for its effect on membrane properties.
